2014 KCA/13thIKCS Chicago Rare Kidney Cancer:Chromophobe RCC

James Hsieh MD PhD MSKCC Translational Kidney Cancer Research Program (TKCRP) presents13thIKCS Chicago Rare Kidney Cancer:Chromophobe RCC at the Kidney Cancer Association meeting in Chicago 2014

Advertisement Single Below Content

2014 KCA/13thIKCS Chicago Rare Kidney Cancer:Chromophobe RCC

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

2014 KCA/13thIKCS Chicago Rare Kidney Cancer: Chromophobe RCC

Related Posts

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

2014 KCA/13thIKCS Chicago Rare Kidney Cancer:Chromophobe RCC